Article and Video CATEGORIES
ALERT: The links for the podcasts are now fixed.
Here's the question and answer session with Drs. Mary Pinder and Nasser Hanna following their presentations on the lung cancer highlights from the ASCO 2011 annual meeting (Dr. Pinder's on SCLC, early stage NSCLC, and mesothelioma here, and Dr. Hanna's on advanced NSCLC here), covering a lot of ground on timely issues raised from the conference. The program and podcast were developed in partnership with LUNGevity Foundation.
Below is the audio and video versions of the podcast, as well as the transcript and figures.
[powerpress]
asco-2011-highlights-in-lung-cancer-qa-audio-podcast
asco-2011-highlights-in-lung-cancer-qa-session-transcript
asco-2011-highlights-in-lung-cancer-qa-session-figures
But if that list of questions and answers doesn't cover every question YOU have in response to the ASCO presentations, feel free to ask the stragglers here.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…